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Two proteins co-operate in the proteolytic cleavage of
mitochondrial precursor proteins: the mitochondrial
processing peptidase (MPP) and the processing enhancing
protein (PEP). In order to understand the structure and
function of this novel peptidase, we have isolated mutants
of Saccharomyces cerevisiae which were temperature
sensitive in the processing of mitochondrial precursor
proteins. Here we report on the mif2 mutation which is
deficient in MPP. Mitochondria from the mif2 mutant
were able to import precursor proteins, but not to cleave
the presequences. The MPP gene was isolated. MPP is
a hydrophilic protein consisting of 482 amino acids.
Notably, MPP exhibits remarkable sequence similarity
to PEP. We speculate that PEP and MPP have a common
origin and have evolved into two components with
different but mutually complementing functions in
processing of precursor proteins.
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Introduction
During recent years a considerable amount of information
has become available on how nuclear-coded proteins are
imported into mitochondria (for reviews see Hay et al., 1984;
Wickner and Lodish, 1985; Pfanner and Neupert, 1987).
It has been found that most, but not all, proteins are initially
made as precursors which carry amino-terminal pre-
sequences. These presequences have a targeting function
to direct the precursors to the mitochondria (Hurt et al.,
1984; Horwich et al., 1985, 1986; Emr et al., 1986; Keng
et al., 1986; Vasarotti et al., 1987). They are cleaved during
or after entry of the precursors into the mitochondrial matrix.
Mitochondria possess an import machinery which includes
surface receptors, which can recognize precursors (Zwizinski
et al., 1984), and membrane components, which can
facilitate their insertion into the outer membrane and
movement into the interior of mitochondria (R.Pfaller et al.,
submitted). Translocation contact sites in which outer and
inner membranes are in close proximity are involved in
channelling proteins to the inner membrane and matrix
(Schleyer and Neupert, 1985; Hartl et al., 1986, 1987a,b;
Schwaiger et al., 1987; Pfanner et al., 1987a,b). Subsequent
steps involve the proteolytic cleavage (Bohni et al., 1980;
Miura et al., 1982; Conboy et al., 1982; McAda and
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Douglas, 1982; Schmidt et al., 1984; Hawlitschek et al.,
1988; Witte et al., 1988) and concomitant sorting into the
different mitochondrial subcompartments (Hard et al., 1986,
1987a). The transport pathways of a number of precursors
have been described in considerable detail. Procedures have
been developed to halt precursors at various distinct steps
(Pfanner et al., 1988). In order to understand fully the
molecular mechanisms of protein import it is essential to
identify and characterize the components involved. This is,
however, hampered by a number of experimental difficulties.
One is the presence of these proteins in only minute amounts,
another is the problem of being able to assay for precise
function of the various protein components of the import
machinery.
A possible approach to characterize such protein
components is to analyze mutations which affect the import
reaction. A combined effort of molecular genetics and
biochemical analysis may therefore be expected to be of great
advantage in identifying the unknown components. Indeed,
in previous studies mutants affecting mitochondrial protein
import have been isolated and partly characterized (Yaffe
and Schatz, 1984; Yaffe et al., 1985).
In this report we describe a new screen for mutants of
Saccharomyces cerevisiae temperature-sensitive (ts) defective
in mitochondrial importfunctions (mif-mutants). Mutants of
three complementation groups were obtained by this pro-
cedure and were characterized by accumulation of uncleaved
precursor proteins at the non-permissive temperature. One
of the ts-lethal mutations, mif2, was investigated in detail.
By genetic crossing, mif2 was found to correspond to the
mas2 mutation described by Yaffe and Schatz (1984). On
the basis of our analysis of its phenotype in vivo and in vitro
we conclude that the mutation affects the mitochondrial
processing peptidase (MPP). This is the catalytic component
of the mitochondrial processing activity, which together with
the previously identified processing enhancing protein (PEP)
is required for cleaving the targeting signals of precursor
proteins in the mitochondrial matrix (Hawlitschek et al.,
1988). MPP is a protein with a mol. wt of 53 000. Its
primary structure was determined by sequencing of the
isolated gene. The derived amino acid sequence of MPP
bears notable similarities to that of PEP, suggesting that the
respective genes are of common evolutionary origin.
Results
Isolation of conditional mutants defective in
mitochondrial protein import
In order to design a strategy for isolation of conditional
yeast mutants affecting the mitochondrial import machinery,
we first considered the phenotype of such mutants. Since
a multiplicity of essential biochemical steps reside in
mitochondria, critical not only to respiration and energy
metabolism but also to amino acid and lipid metabolism, the
absence of these enzymes in their mature, active forms, and
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the resulting blockade of these pathways, should be lethal.
Implicit in this assumption is that the pathway of entry of
some or all of the subunit precursors of these various
enzymes is shared, such that mutations affecting components
of the import machinery would affect a host of entering
precursors.
To develop an efficient screening procedure, permitting
rapid analysis of large numbers of ts-lethals, we exploited
previous findings. Cheng et al. (1987) transformed a yeast
strain (arg3) deficient in ornithine transcarbamylase (OTC)
with a plasmid containing the coding sequence for human
OTC joined with a gall operon promoter. Upon induction
of human OTC the precursor was imported by the mito-
chondria, cleaved to the mature-sized subunit and assembled
into active enzyme. We reasoned that in a ts-lethal mutant
affecting mitochondrial import no OTC enzyme activity
would be produced at the non-permissive temperature
because only mature-sized subunit, assembled into the
trimeric form, exhibits enzyme activity. Neither the non-
cleaved precursor nor non-assembled mature-sized subunit
are enzymatically active (Kalousek et al., 1984). A bank
of ts-lethals was produced using ethylmethanesulfonate
mutagenesis. Cultures of individual mutants were subjected
to an assay in which cells were shifted to non-permissive
temperature (37°C) and expression of OTC precursor was
simultaneously induced from the gall promoter. After 2 h
cells were harvested and OTC enzyme activity was deter-
mined to analyze whether the import pathway was functional.
The host strain as well as the majority of the ts-lethal mutants
contained significant levels of activity. However, - 10% of
the mutants were lacking activity.
Approximately 1500 mutants lacking OTC activity were
analyzed by immunoblot analysis for accumulation of OTC
precursor. Twenty-four mutants were found to accumulate
precursor at non-permissive temperature. These mutants
produced both mature-sized OTC subunits and OTC enzyme
activity at the permissive temperature. In pairwise matings,
they were found to fall into three distinct genetic comp-
lementation groups. They were designated mifl-3, for
'mitochondrial import functions'. mif2, containing 12 alleles,
proved to be unable to complement an allele of the mutant
mas2 previously isolated by Yaffe and Schatz (1984),
indicating that these alleles involve the same gene. This was
confirmed by the observation that the mif2 alleles we had
isolated accumulated at non-permissive temperature the
precursor of the endogenous yeast mitochondrial FIATPase
subunit / (Flo) (not shown).
Mitochondria from mif2 cells lack MPP activity at the
non-permissive temperature
We first analyzed whether mitochondria isolated from cells
bearing the mif2 allele B35.5 were able to import precursor
proteins destined to different submitochondrial compart-
ments. Mutant mitochondria which had been exposed to
37°C for 10 min were found to translocate the precursors
of the Rieske Fe/S protein (complex Ill) and of Flof into a
position protected against externally added proteinase K. In
contrast to mitochondria isolated from wild-type cells, mutant
mitochondria were unable to process proteolytically the
imported precursors. The precursor of ADP/ATP carrier
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Fig. 1. Proteolytic processing of p-Fe/S accumulated in the matrix of wild-type and mutant mitochondria. Mitochondria were isolated from wild-type
and B35.5 cells grown at the permissive temperature. They were incubated for 20 min at 25°C in the presence of reticulocyte lysate containing
radiolabeled precursor of Fe/S protein and ATP and NADH (1 mM each). EDTA and o-phenanthroline (7.5 mM and 1 mM final concentrations
respectively) were included in the import reaction to block the processing peptidase in the matrix. Import was stopped by addition of valinomycin,
the incubations were 3-fold diluted with BSA buffer containing 1 mM EDTA and 1 mM o-phenanthroline and were divided into five aliquots each
(reactions 1-5 and 6-10). Reactions 2-5 and 7-10 were treated with proteinase K (15 ig/ml final concentration). Afterwards mitochondria were
reisolated and resuspended at 250 Ag protein/ml in BSA buffer containing PMSF and N.crassa protease inhibitor. EDTA and o-phenanthroline were
added (0.5 mM each) to maintain the block of the processing peptidase. Reactions 1-3 and 6-8 were then incubated for 10 min at 25°C, reactions
4 and 9 at 30°C, and reactions 5 and 10 at 37°C. Then MnCl2 (2 mM final concentration) was added to reactions 3-5 and 8-10 to relieve the
block of the processing peptidase. Incubation was continued for 15 min at the respective temperature except for reactions 5 and 10 which were
adjusted to 30°C. Mitochondria were reisolated from all reactions, and analyzed by SDS-PAGE and fluorography. Abbreviations: p, precursor;
i, intermediate; m, mature.
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Processing peptidase of yeast mitochondria
which does not contain a cleavable presequence was also
translocated with the same efficiency into mutant and wild-
type mitochondria and was protected from added protease
in both cases (not shown).
The proteolytic processing of precursors accumulated in
the matrix space of mitochondria from mutant and wild-type
was assayed independently of the membrane translocation
event. Precursor of the Fe/S protein was imported into
isolated mitochondria under conditions where the metal-
dependent matrix-processing peptidase was inhibited (i.e.
in the presence of EDTA and orthophenanthroline) (Figure
1). This led to the accumulation of p-Fe/S soluble in the
matrix (Hartl et al., 1986). After import at the permissive
temperature, valinomycin was added to dissipate the
mitochondrial membrane potential. Mitochondria were
treated with proteinase K to digest precursors exposed at
the surface. The mitochondria were further incubated for
10 min at 25, 30 or 37°C. Then the inhibition of the
matrix-processing peptidase was relieved by addition of
Mn2+ ions and incubation was continued for 15 min at the
respective temperatures (Figure 1, lanes 3-5 and 8-10).
Controls showed that both mutant and wild-type mito-
chondria had efficiently accumulated p-Fe/S in the matrix
(Figure 1, lanes 1,2 versus lanes 6,7). In wild-type
mitochondria p-Fe/S was completely processed to m-Fe/S
after reactivation of the processing peptidase. If mitochondria
had been exposed to 37°C, processing to m-Fe/S still
occurred although at a somewhat lower rate (Figure 1,
A
-r._
0
c0
L
C)_
0)
0)
C)
0-0~
B
m-H
F-
-
i
-
e_
[- _
e ..-..F
_
_ ..
re4_ w w lane 5). The ability of mutant mitochondria to processaccumulated precursor was slightly reduced at the permissivetemperature and was completely missing at the non-permissive temperature (Figure 1, lanes 8-10 versus lanes3-5). Notably, the second proteolytic processing step ofintermediate-sized Fe/S (i-Fe/S) to m-Fe/S was not affectedin the mutant (Figure 1, lane 10 versus lane 7). Proteolyticcleavage of i-Fe/S to m-Fe/S which also takes place insidethe inner membrane is most probably performed by anenzyme different from processing peptidase (Hartl et al.,1986; F.-U.Hartl and W.Neupert, unpublished).These results indicated that the mutant mitochondria aredefective in the activity of the metal-dependent processingpeptidase in the matrix at the non-permissive temperature.To prove this further, the activity of the processing enzymewas measured in detergent extracts of mitochondria. In suchextracts proteolytic cleavage of precursor proteins has beenshown to be dependent on two mitochondrial components:MPP itself and PEP. The latter component stronglystimulates the activity of MPP (Hawlitschek et al., 1988).Mitochondria from wild-type and mutant were pre-incubated at 25 or 37°C and detergent extracts were thenprepared. Radiolabeled precursor proteins were added andprocessing activities were determined (Figure 2A). ExtractFig. 2. Processing of cytochrome b2 precursor by matrix extractsprepared from wild-type and mutant mitochondria. Aliquots ofwild-type and mutant mitochondria (B35.5) were suspended at 5 mgprotein/mi in SEM (0.25 M sucrose, 1 mM EDTA, 10 mM Mops,pH 7.2) containing 100 yg/ml of N.crassa protease inhibitor and 1 mMPMSF. They were incubated for 10 min at 25 or 37°C. Mitochondriawere then reisolated by centrifugation and solubilized at 0°C at aconcentration of 1.5 mg protein/mi in extraction buffer (1% TritonX-100, 100 mM NaCl, 30 mM Tris, 1 mM PMSF, 100 1tg/miprotease inhibitor of N.crassa, pH 7.4). Insoluble material wasremoved by centrifugation for 10 min at 45 000 g. (A) Mitochondrialextracts corresponding to 15 yg of mitochondrial protein from wild-type (columns 1 and 4) and B35.5 cells (colunns 2, 3 and 5)pretreated at 25°C (columns 1-3) or 37°C (columns 4 and 5) wereincubated for 30 min at 25°C in the presence of 5 IL reticulocytelysate containing radiolabeled precursor of cytochrome b2. MnCl2 andMgCl2 were added (final concentration 1 mM each). The volume ofthe processing assay was adjusted to 100 /1 with extraction bufferlacking NaCl. In reaction 3 processing activity was inhibited byaddition of 5 mM EDTA. In reaction 6 extract from wild-typemitochondria corresponding to 7.5 jig protein was assayed. In reactions7 and 8 wild-type extracts were mixed with extracts of B35.5
mitochondria (each corresponding to 7.5 jsg protein) pretreated at 25°C
(column 7) and 37°C (column 8). Processing reactions were stopped
by addition of trichloroacetic acid (10% final concentration). After
incubation for 20 min on ice, protein precipitates were recovered by
centrifugation and were analyzed by electrophoresis and fluorography.
Intermediate-sized cytochrome b2 produced from the precursor was
quantified by laser densitometry. The processing activity of
mitochondrial extracts from wild-type mitochondria preincubated at
25°C was set to 100%. (B) A Triton extract of N.crassa mitochondria
(prepared as in A) was diluted 10-fold with extraction buffer. To
aliquots corresponding to 5 yg of mitochondrial protein (column 1)
antiserum directed against MPP and protein A-Sepharose was added
to deplete the extracts of processing activity. After centrifugation,
processing activity was assayed in the resulting supematant (column 2)
and pellet (column 3). Extracts of 370C pretreated B35.5 mitochondria
(corresponding to 10 yg of protein) (columns 4-7) were assayed
either separately (column 4) or were mixed with a total extract of
Neurospora (column 5), or a Neurospora supematant depleted of MPP
(column 6), or a pellet containing the immunoadsorbed MPP (column
7). Processing activities were measured as in (A) and are expressed as
percentages of the activity of the total Neurospora extract.
Abbreviations: Sup, supematant of N.crassa mitochondrial extract
depleted of MPP; pellet, antibody-protein A-Sepharose complex
with adsorbed MPP.
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Fig. 3. Definition of MPP gene by DNA-fragment-mediated
transformation of B35.5 cells. The fragments indicated were obtained
as described in Materials and methods and represent deletion
derivatives of an original 5.0-kb DNA fragment that could confer
growth to B35.5 cells at 37°C. Rescuing fragments are designated by
' + fragments that failed to rescue by '-'. The arrow indicates the
open reading frame determiined by DNA sequencing.
from mutant mitochondria preincubated at 25°C was able
to process precursor to cytochrome b2 with the same
efficiency as extract from wild-type mitochondria (Figure
2A, column 2 versus column 1). In contrast, extract from
mutant mitochondria preincubated at 37°C was completely
devoid of processing activity (Figure 2A, column 5 versus
column 4). This lack of activity was not the result of non-
specific proteolysis since the highly protease-sensitive pre-
cursor protein contained in these reactions was not degraded.
Non-specific inhibition of processing in extracts of mutant
mitochondria was excluded by the observation that process-
ing in extracts from wild-type mitochondria was not inhibited
by addition of mutant extract (Figure 2A, columns 7 and
8). In a further experiment extract from Neurospora
mitochondria which had been depleted of MPP by immuno-
absorption did not restore activity in mutant extract (Figure
2B, column 6 versus column 4). On the other hand, extracts
from mutant mitochondria preincubated at non-permissive
temperature stimulated the activity of Neurospora MPP
immunoadsorbed to protein A-Sepharose (Figure 2B,
column 7 versus column 3).
These observations show that in the mif2 mutant the MPP
component of the processing enzyme is defective in a ts
manner, whereas the other component of the processing
enzyme, PEP, is present in active form. Since the B35.5
allele behaves as a single ts-nuclear mutation in genetic
crosses, the affected gene is coding for MPP, the catalytic
component of the processing enzyme.
Isolation and structural analysis of the MPP gene
The strain bearing the B35.5 allele was transformed with
a yeast library containing genomic DNA fragments inserted
into a centromere-bearing plasmid, and the transformed cells
were plated at 37°C. DNA was prepared from a number
of colonies that grew at 37°C and used to transform
Escherichia coli. Plasmids from ampicillin-resistant bacterial
colonies were isolated. They contained inserts ranging in size
from 10 to 20 kb. Restriction analysis with EcoRI revealed
the presence of a 5.0-kb fragment in all of these plasmids,
suggesting that this segment of genomic DNA lies within
or encompasses the MPP gene. To define the gene further,
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Fig. 4. Nucleotide sequence of MPP gene and deduced amino acid
sequence. Numbering of the two sequences is referenced from the ATG
codon that commences the open translational reading frame. A protein
of 482 residues is predicted.
rescue experiments were carried out using fragments that
were deletion derivatives (Figure 3). The fragments were
used to transform B35.5 cells which were plated at 37°C.
A number of rescuing segments were identified, the smallest
of which was 2 kb in size.
The DNA sequence of this 2-kb rescuing fragment was
determined (Figure 4). A continuous open reading frame
comprising 1446 nucleotides was identified. This corre-
sponded with the size of an RNA from wild-type yeast that
hybridized in Northern analysis with a probe derived from
the 2-kb fragment (not shown). A protein of 482 amino acid
residues is predicted from the open reading frame. The
sequence shows an abundance of hydrophilic amino acids
and lacks stretches of hydrophobic amino acids that are
characteristic of membrane-spanning proteins. The overall
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Table I. Subcellular localization of the MIF2 gene product
Protein MIF2 CS AAC
Homogenate 100 100 100 100
PMS 88.4 7.5 10.6 2.5
Mitochondria 9.2 92.3 86.5 93.7
Spheroplasts prepared from wild-type cells by zymolyase treatment
were broken in a Dounce homogenizer. Cell debris was removed by
centrifugation for 5 min at 2000 g. The resulting homogenate was
fractionated into a mitochondrial fraction and a postmitochondrial
supernatant (PMS) by centrifugation for 15 min at 45 000 g. Fractions
were analyzed for protein content and citrate synthase (CS) activity
(Srere, 1969). Amounts of MIF2 gene product and ADP/ATP carrier
(AAC) were determined by SDS-PAGE and immunoblotting of
aliquots of the different cell fractions. Values are expressed as
percentages of total content in the homogenate.
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Fig. 5. Removal of processing activity from a mitochondrial extract by
antibodies against the MPP gene product. (A) A mitochondrial pellet
(50 Ag) was dissociated in SDS-containing buffer, separated by
SDS-PAGE and electrotransferred to nitrocellulose paper.
Immunolabeling was performed with an antiserum raised in rabbits
against a fusion protein containing most of the MPP gene product and
part of the bacterial trpE sequence. Bound antibodies were visualized
by decoration with [14C]protein A and autoradiography. A band with
an apparent mol. wt of 52 000 is indicated. (B) Immunoglobulins
directed against the MPP gene product (see above) or
preimmunoglobulins contained in 0, 2.5, 7.5 or 15 itl of immune or
preimmune serum respectively were prebound to protein
A-Sepharose. Mitochondrial Triton extracts corresponding to 15 tg of
protein contained in 100 A1 of extraction buffer were added to the
Sepharose beads and the MPP protein was immunoadsorbed by end
over end mixing for 2 h at 4°C. The beads were collected by
centrifugation and the supernatants were tested for their activity in
processing the precursor to cytochrome b2 (see legend to Figure 2).
Values are expressed as percentages of the activity of a control extract
to which no antiserum had been added.
character is that of a soluble protein. At the N terminus three
basic residues are present at positions 3, 8 and 15. The first
acidic residue is at position 17. This may represent a
mitochondrial targeting sequence, though it would be
considerably shorter than the average one. N-terminal
abundance of positively charged residues and absence of
negatively charged residues is a feature observed for virtually
all mitochondrial presequences analyzed to date. So far a
consensus sequence at the cleavage site of presequences has
not been identified. However, recent surveys show that the
configuration of the cleavage site is often -Arg-X' -Y-
(Nicholson and Neupert, 1988). Thus, processing of the
MPP precursor could potentially occur after residues 9 or
16, although this speculation can only be substantiated by
radiosequencing.
The MPP gene supplies an essential function in yeast
To address whether the MPP gene is essential for yeast, a
gene disruption experiment was carried out. A large part
of the coding sequence (nucleotides 286- 1351; see Figure
3) was removed from the plasmid carrying the entire
functional MPP gene and replaced with the URA3 gene. The
Fig. 6. Import of MPP into isolated mitochondria. In three reactions
reticulocyte lysate containing radiolabeled MPP synthesized by coupled
transcription/translation from the cloned gene was incubated with
mitochondria from wild-type yeast (see legend to Figure 1). Reaction
(a) served as control (lanes 1 and 2). Reaction (b) contained 7.5 mM
EDTA and 1 mM o-phenanthroline to inhibit the mitochondrial
processing peptidase (lanes 3 and 4). In reaction (c) mitochondria were
de-energized by addition of valinomycin (Val) (1 zM final
concentration) (lanes 5 and 6). After 20 min incubation at 25°C, one
half of each reaction was treated with 15 pg/ml proteinase K (lanes 2,
4 and 6); the other halves remained untreated (lanes 1, 3 and 5).
Mitochondria were reisolated and analyzed by electrophoresis and
fluorography.
plasmid was then linearized within the remaining MPP
coding region and used to transform a wild-type diploid
strain. URA+ transformants were selected and were then
sporulated. Twenty-five tetrads were analyzed and in each
case only two out of four spores were viable. In no case
was a viable URA+ spore detected. This indicates that the
MPP gene serves an essential function in yeast.
The MPP gene product is located in the mitochondrial
matrix of yeast and can be imported into isolated
mitochondria
A fusion protein containing the bulk of the MPP gene product
and part of the bacterial trpE sequence was produced in
E. coli and injected into a rabbit to obtain antibodies against
MPP. The antibody recognized in immunoblots of whole
cell extracts and of mitochondrial lysates a protein with an
apparent mol. wt of 52 000 (Figure SA). This corresponds
well to the mol. wt predicted by the amino acid sequence.
In addition, MPP antibodies were able to remove efficiently
the processing activity from mitochondrial detergent extracts
(Figure SB).
The antibody was used to determine the subcellular
localization of the MPP gene product. Yeast cells were
fractionated into a mitochondrial and a postmitochondrial
supematant fraction. As shown in Table I, the 52-kd protein
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was recovered almost completely in the mitochondrial
fraction. Upon subfractionation of mitochondria with
digitonin the 52-kd protein was selectively released with
soluble matrix marker enzymes (not shown). The localization
of the MPP protein in the matrix agrees with our earlier
finding that the catalytic component of the processing
peptidase is a soluble protein of the matrix (Hawlitschek et
al., 1988).
The MPP gene cloned into a Bluescript derivative was
transcribed with T3 RNA polymerase and the product
translated in a rabbit reticulocyte lysate in the presence of[35S]methionine. A major product of 53 kd was detected in
the lysate mixture which could be immunoprecipitated with
the antibody against MPP described above. Upon incubation
with isolated mitochondria this translation product was
imported into a location where it was inaccessible to
externally added proteinase K (Figure 6, lanes 1 and 2).
Import was dependent on the mitochondrial membrane
potential (Figure 6, lanes 5 and 6). Newly synthesized
MPP protein, both contained in the reticulocyte lysate
and associated with the outer membrane of de-energized
mitochondria, exhibited a slightly higher apparent mol. wt
compared to the fully imported species. The reduction of
mol. wt of the imported species was not observed if metal
chelators (EDTA and o-phenanthroline) were included during
the import reaction to inhibit the mitochondrial processing
enzyme (Figure 6, lanes 3 and 4). This suggests proteolytic
processing of MPP; however, further analysis is required.
It is an intriguing question as to whether MPP is made
as a precursor which is processed by the mitochondrial
processing enzyme. If this is the case, the continuous
presence of the active enzyme in mitochondria is a pre-
requisite for the formation of mitochondria, unless the
precursor of MPP has the capacity for autocataytic cleavage.
Discussion
Biochemical analysis of the mit2 mutation showed that
the MIF2 (or MAS2) gene encodes MPP, the catalytic
component of the mitochondrial processing peptidase. Two
components, MPP itself and PEP, have been found to be
required for proteolytic processing of mitochondrial
precursor proteins (Hawlitschek et al., 1988). The latter
component is encoded by the MASI gene (equivalent to
A
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MIFI) (Witte et al., 1988). The evidence that MIF2 specifies
MPP is as follows: (i) mutant cells accumulate mitochondrial
precursor proteins at the non-permissive temperature; (ii)
isolated mutant mitochondria pretreated at the non-permissive
temperature are able to translocate precursor proteins across
the mitochondrial membranes but are unable to process them
proteolytically; (iii) extracts of Neurospora mitochondria
depleted of MPP cannot restore processing activity in extracts
of mutant mitochondria; (iv) antibodies directed against the
MIF2 gene product can efficiently remove the processing
activity from extracts of wild-type mitochondria; (v) the
MIF2 gene product is a soluble protein located in the
mitochondrial matrix.
In summary, the phenotype of the mif2 mutation reflects
the consequences predicted for a deficiency in MPP activity.
The phenotype of the MPP mutant can be mimicked by
inhibiting the processing peptidase with metal chelators. Also
under these conditions import of proteins into mitochondria
occurs independently of proteolytic processing (Zwizinski
et al., 1983; Hartl et al., 1986).
Yeast MPP is a soluble protein of the mitochondrial matrix
which is imported from the cytosol. The amino acid sequence
deduced from the nucleotide sequence is indeed typical for
a hydrophilic protein. MPP consists of 482 amino acid
residues and has an apparent mol. wt of 53 000. It contains
a positively charged amino terminus, a feature shared by
all proteins of the mitochondrial matrix analyzed so far;
however, it is not entirely clear that a short peptide is cleaved
from the protein transcribed and translated from the MPP
gene. We performed a structural comparison of MPP with
yeast and Neurospora PEP whose sequences have been
recently reported (Hawlitschek et al., 1988; Witte et al.,
1988). A striking similarity is seen in the hydropathy plots,
in particular in the N-terminal halves of the three proteins
(Figure 7A). Alignment of the MPP sequence to yeast PEP
showed 26% identity and 48% similarity if isofunctional
amino acid residues are considered (Figure 7B). If
Neurospora PEP is included in the comparison, yeast MPP
has 30% identity to PEP. Identity between Neurospora and
yeast PEP is 52% (68% similarity including isofunctional
residues).
These results strongly suggest an evolutionary relationship
between both components of the processing enzyme. The
functional properties of MPP and PEP, however, are
different. MPP alone has a very low catalytic activity which
is stimulated by PEP as found with the Neurospora enzyme.
PEP alone has no apparent cleavage activity at all. The two
components, on the other hand, do not form a detectable
complex. Furthermore, PEP is present in mitochondria
in large excess with respect to quantity and processing-
enhancing activity. A large part of PEP behaves as peripheral
membrane protein associated with the inner surface of the
inner membrane; in contrast, MPP is completely soluble in
the matrix (Hawlitschek et al., 1988). Assuming a common
origin for the genes of MPP and PEP, the latter component
must have lost (or never have acquired) the ability to cleave
presequences but has probably acquired or preserved the
ability of binding to the presequences of imported precursor
proteins thus enhancing the interaction of MPP with the
cleavage site. Overexpression of the MPP gene inserted into
a 2 jnplasmid in the ts-mutant mif1 (identical with the
previously described masl mutation; Yaffe and Schatz, 1984)
could restore slow growth at the non-permissive temperature
while overexpression of PEP in the MPP mutant did not
(M.Y.Cheng and A.Horwich, unpublished). This indicates
that under conditions where the intrinsic activity of MPP
is sufficiently high, the processing enhancing function of PEP
becomes dispensable. This could be due either to MPP being
sufficient by itself or to MPP taking over some function of
PEP. Recent results with the mifl mutant suggest that in
addition to stimulating cleavage, PEP has a function in
facilitating the translocation of precursor proteins across the
mitochondrial membranes (F.-U.Hartl, A.Horwich and
W.Neupert, unpublished). This might explain why over-
expression ofMPP in the mifl mutant restores growth only
to rates much slower than those observed for the wild-type.
Materials and methods
Yeast strains and growth media
Strain MC3 (Mata, arg 3, ura 3-52, his 4-519, leu 2-112) was generated
by crossing the previously described strain RPl 1 (Cheng et al., 1987) with
the strain JRY-438, a gift of Giorjana Barnes and Jasper Rine (Barnes
and Rine, 1985). MC3:YIPGALOTC was generated by lithium acetate
transformation (Ito et al., 1983) of strain MC3 with SmaI-linearized
pYIPGALOTC. YPD: 1% yeast extract, 2% peptone, 2% dextrose; YPEG:
1% yeast extract, 2% peptone, 2% ethanol and 3% glycerol. Synthetic
minimal media: 0.64% yeast nitrogen base supplemented with 20,ug/ml
each of arginine, leucine and histidine.
DNA manipulations
pYIPGALOTC was generated by joining a PvuI-SailI fragment of the
plasmid pGALOTC, containing the Gall operon promoter linked to OTC
cDNA, with a Pvu I-Sal I fragment of the plasmid pYIP5, bearing the URA3
gene. The MPP gene was isolated by plasmid rescue (Broach et al., 1979)
using a yeast DNA CEN library (Rose and Fink, 1987). Both the definition
of functional regions of the rescuing plasmid (i.e. the rescuing plasmid with
the smallest insert) and dideoxy DNA sequence analysis employed deletion
constructs generated using exonuclease IIH and mung bean nuclease
(Stratagene). Deletion plasmids were tested for their ability to restore growth
at 37°C by linearizing them with EcoRI and transforming the mif2 allele
B35.5 using the spheroplast method (Hinnen et al., 1978). Cells were directly
plated on YPD at 37°C. Five micrograms of plasmid DNA typically yielded
600-2000 colonies per 3 x 107 cells. Deletion plasmids were sequenced
using the modified dideoxy method of Tabor and Richardson (1987),
employing double-stranded template DNAs isolated by the alkaline lysis
method (Maniatis et al., 1982). Additional clones for sequence analysis were
generated by complete digestion of the 5-kb rescuing DNA fragment with
either Sau ilA or Hae II followed by insertion of the collection of respective
fragments into pBluescript (Stratagene).
Isolation of mutants
A culture of MC3:YIPGALOTC cells was mutagenized with 3% ethyl-
methanesulfonate to produce 40-60% survival (Sherman et al., 1986).
Portions of the culture were grown on YPEG plates at 23 °C and the clones
were colony purified on YPEG at 23 °C and retested for absence of growth
on YPD at 37°C. Temperature-sensitive colonies were next subjected to
an assay involving a simultaneous shift from permissive to non-permissive
temperature and from ethanol/glycerol to galactose-containing medium to
induce expression of OTC. In particular, ts colonies were first grown for
3 days on YPEG plates at 23°C. Individual colonies were then resuspended
in 2 ml of YPEG medium to an OD6W of 2 and incubated at 37°C for
30 min with vigorous agitation. Galactose was added to 2% and the culture
was then grown for 2 h. One milliliter of the culture was lysed by the addition
of 100 Al 1.85 M NaOH containing 7.4% ,B-mercaptoethanol and the extract
was processed for SDS-PAGE as previously described (Yaffe and Schatz,
1984). To the second milliliter of culture, 1 ml of 'spheroplast solution'
was added, containing 2.8 M sorbitol, 20 mM KPi pH 7.4, 0.5% (3-
mercaptoethanol, 20 mM NaN3 and 100 Agg/ml zymolyase 100T (Miles).
The mixture was incubated at 37°C for 30 min without shaking, then chilled
to 40C and centrifuged for 5 min at 1000 g to pellet the spheroplasts. Pelleted
spheroplasts were resuspended in 100 !d of a solution containing 0.1% Triton
X-100, 20 mM NaN3 and 20 mM KPi, pH 7.4. and the spheroplasts were
lysed by three cycles of freezing and thawing. The extract was then assayed
for OTC activity as previously described (Kalousek et al., 1978) except
that incubation time was extended to 1 h. Colonies exhibiting significantly
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reduced levels of OTC activity in the shift assay were examined by
immunoblot analysis.
Isolation of mitochondria and import in vitro
Wild-type and mutant yeast were grown for - 16 h at 23°C in YPEG until
a concentration of 1 g wet weight of cells/l of culture was reached. Isolation
of mitochondria was performed essentially as described previously (Daum
et al., 1982; Hartl et al., 1987a) except that during treatment of cells with
zymolyase, protease inhibitor of Neurospora (Schmidt et al., 1984) was
added to a concentration of 100 jig/ml. Growth of N.crassa and isolation
of Neurospora mitochondria was carried out as published (Hartl et al., 1986).
Radiolabeled precursors of Fe/S protein of complex III, ATPase FloB and
ADP/ATP carrier were synthesized by coupled transcription/translation
(Pelham and Jackson, 1976; Krieg and Melton, 1984; Stueber et al., 1984)
of the respective cDNAs cloned into expression vector pGEM3. In the case
of cytochrome b2 a genomic clone was used (Guiard, 1985). For import
in vitro, isolated mitochondria were incubated with reticulocyte lysates
containing [35S]methionine-labeled precursor proteins 5-fold diluted with
BSA buffer (3% bovine serum albumin, 80 mM KCl, 2.5 mM MgCl2,
10 mM Mops, pH 7.2) (Hartl et al., 1987a; Pfanner and Neupert, 1987b).
Treatment of mitochondria with proteinase K after import, inhibition of the
mitochondrial processing peptidase and reisolation of mitochondria from
the import reactions were carried out as previously described (Hartl et al.,
1987a).
Miscellaneous
The following procedures were performed according to published methods:
in vivo labeling of cells with [ 5S]methionine (Yaffe and Schatz, 1984);
digitonin fractionation of mitochondria (Hartl et al., 1987a); immuno-
precipitation of OTC and FloB from cell extracts (Cheng et al., 1987);
immunoprecipitation of MPP from mitochondrial Triton extracts and assay
of processing activities (Hawlitschek et al., 1988); precipitation of protein
with trichloroacetic acid (Hartl et al., 1987a); protein determination
(Bradford, 1976); SDS-PAGE on 8.5% (OTC) and 15% (Flo,
cytochrome b2, Fe/S-protein, ADP/ATP carrier) polyacrylamide gels
(Laemmli, 1970); immunoblotting (Burnette, 1981); quantitation of
fluorographs by densitometry (Hartl et al., 1986). Sequence analyses were
compiled using University of Wisconsin Genetics Computer Group
(UWGCG) software (Devereux et al., 1984).
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